Rhumbline Advisers Trims Stock Holdings in McKesson Corporation $MCK

Rhumbline Advisers lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 0.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 259,722 shares of the company’s stock after selling 2,293 shares during the period. Rhumbline Advisers’ holdings in McKesson were worth $200,646,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the stock. Brighton Jones LLC boosted its stake in McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares during the period. Caxton Associates LLP purchased a new stake in shares of McKesson in the first quarter worth about $233,000. Sivia Capital Partners LLC lifted its holdings in shares of McKesson by 77.9% in the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares in the last quarter. Concurrent Investment Advisors LLC boosted its position in shares of McKesson by 11.9% in the second quarter. Concurrent Investment Advisors LLC now owns 1,987 shares of the company’s stock valued at $1,456,000 after acquiring an additional 211 shares during the period. Finally, CWM LLC grew its stake in McKesson by 5.7% during the second quarter. CWM LLC now owns 14,614 shares of the company’s stock valued at $10,709,000 after acquiring an additional 792 shares in the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MCK has been the topic of several recent analyst reports. Barclays initiated coverage on shares of McKesson in a research note on Monday, December 8th. They issued an “overweight” rating and a $960.00 target price on the stock. Wall Street Zen cut shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Evercore reissued an “outperform” rating and set a $1,000.00 price objective on shares of McKesson in a research note on Thursday, November 6th. UBS Group boosted their target price on McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Finally, Weiss Ratings lowered McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $937.07.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the sale, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.08% of the company’s stock.

McKesson Stock Down 2.9%

MCK opened at $934.41 on Wednesday. The business’s fifty day simple moving average is $832.63 and its 200 day simple moving average is $783.87. McKesson Corporation has a 52 week low of $585.22 and a 52 week high of $971.93. The stock has a market cap of $114.46 billion, a PE ratio of 26.87, a P/E/G ratio of 1.55 and a beta of 0.40.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.